Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 25;83(3):453-63.
doi: 10.3797/scipharm.1501-16. Print 2015 Jul-Sep.

Cost-Effective Isolation of a Process Impurity of Pregabalin

Affiliations

Cost-Effective Isolation of a Process Impurity of Pregabalin

Lakkireddy Prakash et al. Sci Pharm. .

Abstract

Cost-effective isolation methods were developed on preparative HPLC, flash LC, and simulated moving bed (SMB) to prepare the process impurity, 3-(aminomethyl)-5-methylhex-4-enoic acid (4-ene impurity), of pregabalin. By a thorough experimental study on the different isolation techniques available, it was concluded that SMB was the most cost-effective. Hence, it was a continuous chromatography that utilized the advantage of SMB so that a high quantity of the impurity was generated in a short period of time. SMB was equipped with eight reversed-phased columns and was used to separate the process impurity of pregabalin. The effects of flow rate in zone 2 (Q2) and 3 (Q3), as well as switching time, on the operating performance parameters like purity, productivity, and desorbent consumption were studied. Operating conditions leading to more than 90% purity in the raffinate outlet stream were identified, together with those achieving optimal performance. All of these developed methods are novel, cost-effective, and can be applied to the isolation of other process- and stability-related impurities of pregabalin.

Keywords: Flash chromatography; Impurity; Isolation; Pregabalin; Preparative HPLC; Simulating moving bed.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Synthesis of pregabalin
Fig. 2
Fig. 2
Synthetic enhancement of the impurity
Fig. 3
Fig. 3
HPLC chromatogram of crude pregabalin
Fig. 4
Fig. 4
Prep HPLC and flash LC impurity isolation chromatograms
Fig. 5
Fig. 5
Purity chromatograms of the 4-ene impurity isolated by prep HPLC, flash LC, and SMB
Fig. 6
Fig. 6
Effect of zone 2 flow rates on purity
Fig. 7
Fig. 7
Effect of zone 3 flow rates on purity
Fig. 8
Fig. 8
Effect of switching time on purity

Similar articles

References

    1. WebMD. Pregabalin. http://www.webmd.com/drugs/drug-93954-pregabalin+oral.aspx .
    1. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009. p. CD007076. http://dx.doi.org/10.1002/14651858.CD007076.pub2 . - PMC - PubMed
    1. Wensel TM, Powe KW, Cates ME. Pregabalin for the treatment of generalized anxiety disorder. Ann Pharmacother. 2012;46:424–429. http://dx.doi.org/10.1345/aph.1Q405 . - PubMed
    1. Bandelow B, Wedekind D, Leon T. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev Neurother. 2007;7:769–781. http://dx.doi.org/10.1586/14737175.7.7.769 . - PubMed
    1. Owen RT. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety. Drugs Today. 2007;43:601–610. http://dx.doi.org/10.1358/dot.2007.43.9.1133188 . - PubMed

LinkOut - more resources